We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Point of Care

Image: TruHeart technology aims to prevent heart disease mortality by early point-of-care diagnosis (Photo courtesy of Neuome Peptides)

POC Assay Could Diagnose Acute Coronary Syndrome in 3-5 Minutes

A cardiac-specific quantitative test using a finger-prick sample could offer results in 3-5 minutes at the point of care and help in identifying cardiovascular problems anywhere. More...
19 Dec 2022
Image: Detecting SARS-CoV-2 with a new Quenchbody immunosensor (Photo courtesy of Tokyo Tech)

New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases

Researchers have developed a new immunosensor based on Quenchbody technology that shows great potential as a fast, inexpensive, and convenient tool to detect SARS-CoV-2. This highly efficient diagnostic approach will be useful not only for point-of-care testing, but also for high-throughput epidemiological studies of COVID-19 and other emerging infectious diseases. More...
19 Dec 2022
Image: The innovative, next generation LumiraDx Point of Care Diagnostic Platform (Photo courtesy of LumiraDx)

POC Molecular TB Test Could Enable Clinicians to Begin Appropriate Treatment Immediately

A new molecular TB testing system currently under development aims to provide highly accurate results at a low price at the point of care, enabling clinicians to immediately commence appropriate treatment and patient management to maximize health outcomes and minimize further spread of infection. More...
15 Dec 2022
Image: An early sepsis recognition platform could be more rapid, affordable and accessible (Photo courtesy of Pexels)

Early Sepsis Recognition Platform Could Identify Pre-Symptomatic Patients at POC Using Culture-Free Diagnostic Test

A new diagnostic system for early-stage sepsis condition could allow doctors to predict the future appearance and evolution of sepsis within a short period of time and thus, provide a suitable clinical response even before the symptoms arise. More...
14 Nov 2022
Image: A breakthrough technology intends to reshape the future of diagnostic testing (Photo courtesy of IdentifySensors)

New Digital Platform Technology Aims to Disrupt 50-Year-Old PCR Testing for Similar-Symptom Pathogens

A disruptive new diagnostic testing platform that uses electronic nanosensors to detect the genetic material of numerous pathogens could reshape the future of diagnostic testing. More...
14 Nov 2022
Image: Photo of the group’s circuit board for the biosensor (Photo courtesy of University of Florida)

Hand-Held POC Biosensor Quickly and Accurately Detects Oral Cancer

Researchers have developed a breakthrough hand-held biosensor that enables quick and accurate detection of oral cancer. The team is now looking forward to demonstrating their integrated solution for cancer and other disease detection via a hand-held point-of-care device with a short detection time and low detection limit. More...
14 Nov 2022
Image: Nanōmix eLab is a mobile, hand-held immunoassay and chemistry diagnostic system (Photo courtesy of Nanomix)

Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System

Mast Group Limited (Liverpool, UK) and Nanomix (Emeryville, CA, USA) have entered into a multi-region distribution agreement wherein Mast will market and distribute the Nanōmix eLab system in the UK, Germany, France, Ireland and South Africa. More...
14 Nov 2022
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Tourniquet System
heidi– mein Tourniquet
Wound Irrigation Solution
Prontosan®


The HospiMedica Point-of-Care Testing channel provides reporting on clinical/medical testing that is performed at the patient's side, near the patient and outside of the clinical laboratory. This would include testing provided by healthcare professionals and remote/field personnel and does not require processing by a central laboratory.